Antony Pfaffle, Director at CorMedix Inc. (CRMD), bought 2,000 shares at $0.32 ($640) on 2011-12-15, disclosed to the SEC on 2011-12-19.
Open-market purchase of $640 CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CRMD | SELL | 2016-06-22 | $127K | — | Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |